Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Christophe Glorieux, Cinthya Enríquez, Constanza Díaz González, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Targeting ROS in cancer: rationale and strategies
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 583-606
Closed Access | Times Cited: 115
Unraveling the Role of Reactive Oxygen Species in T Lymphocyte Signaling
Karsten Gülow, Deniz Tümen, Philipp Heumann, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6114-6114
Open Access | Times Cited: 8
Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It
Eleicy Nathaly Mendoza, Maria Rosa Ciriolo, Fabio Ciccarone
Antioxidants (2025) Vol. 14, Iss. 1, pp. 94-94
Open Access | Times Cited: 1
Gold nanoparticles (AuNPs) decrease the viability of cervical cancer cells by inducing the BAX gene and activating antioxidant enzymes
Noor Alhuda Kamil Shareef, Farshid Zandsalimi, Gholamreza Tavoosidana
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 6
Targeting catalase in cancer
Christophe Glorieux, Pedro Buc Calderón
Redox Biology (2024) Vol. 77, pp. 103404-103404
Open Access | Times Cited: 5
Metabolic Reprogramming at the Edge of Redox: Connections Between Metabolic Reprogramming and Cancer Redox State
José J. Serrano, Miguel Ángel Medina
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 498-498
Open Access
SQSTM1/p62 predicts prognosis and upregulates the transcription of CCND1 to promote proliferation in mantle cell lymphoma
Shuxia Zhang, Fang Huang, Jinfeng Wang, et al.
PROTOPLASMA (2025)
Closed Access
Exploring Chemoprevention in Colorectal Cancer for Patients with Inflammatory Bowel Disease: Mechanisms of Action and Clinical Aspects
Fotios S. Fousekis, Konstantinos Mpakogiannis, Panagiotis Filis, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 229-229
Open Access
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
Rubén López-Hernández, María Magdalena de la Torre-Álamo, Borja García‐Bueno, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 121-121
Open Access
Targeting Nrf2/KEAP1 signaling pathway using bioactive compounds to combat mastitis
Muhammad Zahoor Khan, Liangliang Li, Yandong Zhan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Activation, interaction and intimation of Nrf2 pathway and their mutational studies causing Nrf2 associated cancer
Meena Sahu, Utkarsh Jain
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167764-167764
Closed Access
Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation
Zhuang Li, Rong-Liang Mo, Jun-feng Gong, et al.
Phytomedicine (2024) Vol. 129, pp. 155661-155661
Open Access | Times Cited: 3
The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives
Kęstutis Petrikonis, Jurga Bernatonienė, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1068-1068
Open Access | Times Cited: 3
The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs
Mengyang Zhang, Jing Wang, Runze Liu, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37326-e37326
Open Access | Times Cited: 2
Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review
Zhiyong Long, Xiang Wang, Wei Xiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
In vitro anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 16, pp. 1665-1684
Closed Access | Times Cited: 1
Unraveling the role of heavy metals xenobiotics in cancer: a critical review
Sourav Pal, Sayed Mohammed Firdous
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Extrinsic and Cell-Intrinsic Stress in the Immune Tumor Micro-Environment
Aldo Ummarino, Nicholas Calà, Paola Allavena
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12403-12403
Open Access | Times Cited: 1
The Growth Inhibitory Effect of Resveratrol and Gallic Acid on Prostate Cancer Cell Lines through the Alteration of Oxidative Stress Balance: The Interplay between Nrf2, HO-1, and BACH1 Genes
Delaram Moghadam, Reza Zarei, Amirabbas Rostami, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1220-1232
Closed Access | Times Cited: 1
UBE2C regulates the KEAP1/NRF2 signaling pathway to promote the growth of gastric cancer by inhibiting autophagy
Yunhe Jiang, Bin Liu, Lifu Fu, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 134011-134011
Closed Access | Times Cited: 1
Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma
Chin‐Mu Hsu, Shih‐Yu Kao, Chia‐Hung Yen, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Adverse Effects of Nrf2 in Different Organs and the Related Diseases
Xuemei Jin, Chen Long, Y.F. Yang, et al.
Antioxidants and Redox Signaling (2024)
Closed Access | Times Cited: 1
Hybridisation of in silico and in vitro bioassays for studying the activation of Nrf2 by natural compounds
Bui Quoc Huy Nguyen, Nguyen Thien Han Le, Thi Yen Nhi Nguyen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Downregulation of IL-8 and IL-10 by LRRC8A Inhibition through the NOX2–Nrf2–CEBPB Transcriptional Axis in THP-1-Derived M2 Macrophages
Miki Matsui, Junko Kajikuri, Hiroaki Kito, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9612-9612
Open Access
Solasodine Downregulates ABCB1 Overexpression in Multidrug Resistant Cancer Cells Via Inhibiting Nrf2/Keap1 Signaling Pathway
Pradhapsingh Bharathiraja, Sugumar Baskar, N. Rajendra Prasad
Journal of Cellular Biochemistry (2024)
Closed Access
Page 1 - Next Page

Scroll to top